Literature DB >> 7729897

Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment.

S Inoue1, S Itagaki, F Amano.   

Abstract

Listeria monocytogenes is a facultative intracellular pathogen and survives within phagocytic cells by escaping from phagosomes into the cytoplasm. It has been reported that, in vivo, L. monocytogenes is effectively eliminated through cell-mediated immunity, especially by macrophages which have been immunologically activated by cytokines such as gamma interferon (IFN-gamma). However, this killing mechanism for L. monocytogenes and the role of macrophage activation in this bacterial killing are unclear. We demonstrated the listericidal effect of oxidative radicals induced by lipopolysaccharide (LPS) and IFN-gamma, using a macrophage-like cell line, J774.1, and a mutant cell line, LPS1916. LPS1916 cells do not exhibit normal generation of O2- and H2O2 after treatment with 0.1 microgram of LPS per ml, although J774.1 cells generate 100 times the normal level of oxidative radicals with the same LPS treatment. The growth of L. monocytogenes was strongly inhibited in J774.1 cells pretreated with 0.1 microgram of LPS per ml or the combination of 0.1 microgram of LPS per ml and 10 U of IFN-gamma per ml. On the other hand, in LPS1916 cells, the growth of L. monocytogenes was not inhibited by treatment with LPS only, although LPS1916 cells pretreated with the combination of LPS and IFN-gamma showed moderate inhibition of listerial growth. This killing was not influenced by treatment with NG-monomethyl-L-arginine, which is a strong inhibitor of nitrite oxide generation. Interestingly, J774.1 cells treated with LPS did not show enhanced intraphagosomal killing of a nonhemolytic strain of avirulent L. monocytogenes that lacks the ability to escape from phagosomes, and this killing was not influenced by treatment with NG-monomethyl-L-arginine either. These results suggest that the reactive oxygen radicals are more important than nitric oxide in the mechanism underlying the intracellular killing of virulent L. monocytogenes and that there seem to be different killing mechanisms for virulent and avirulent strains of L. monocytogenes in activated-macrophage cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729897      PMCID: PMC173238          DOI: 10.1128/iai.63.5.1876-1886.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes.

Authors:  M Mitsuyama; K Igarashi; I Kawamura; T Ohmori; K Nomoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

2.  Kinetics of killing Listeria monocytogenes by macrophages: correlation of 3H-DNA release from labeled bacteria and changes in numbers of viable organisms by mathematical model.

Authors:  W A Davies
Journal:  J Reticuloendothel Soc       Date:  1982-12

3.  Gamma interferon induces monocyte killing of Listeria monocytogenes by an oxygen-dependent pathway; alpha- or beta-interferons by oxygen-independent pathways.

Authors:  R Peck
Journal:  J Leukoc Biol       Date:  1989-11       Impact factor: 4.962

4.  Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.

Authors:  S L James; J Glaven
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.

Authors:  L S Anthony; P J Morrissey; F E Nano
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

6.  Listeria ivanovii is capable of cell-to-cell spread involving actin polymerization.

Authors:  I Karunasagar; G Krohne; W Goebel
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Role of bacterial hemolysin production in induction of macrophage Ia expression during infection with Listeria monocytogenes.

Authors:  N E Marshall; H K Ziegler
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

8.  Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes.

Authors:  C J Czuprynski; P M Henson; P A Campbell
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

9.  Effects of Listeria monocytogenes Hemolysin on Phagocytic Cells and Lysosomes.

Authors:  G C Kingdon; C P Sword
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

10.  Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells.

Authors:  H Rosen; S Gordon; R J North
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  The contribution of both oxygen and nitrogen intermediates to the intracellular killing mechanisms of C1q-opsonized Listeria monocytogenes by the macrophage-like IC-21 cell line.

Authors:  C Alvarez-Domínguez; E Carrasco-Marín; P López-Mato; F Leyva-Cobián
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

3.  Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infected cattle, sheep, and goats and in macrophages stimulated in vitro.

Authors:  T W Jungi; H Pfister; H Sager; R Fatzer; M Vandevelde; A Zurbriggen
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

4.  The contributions of reactive oxygen intermediates and reactive nitrogen intermediates to listericidal mechanisms differ in macrophages activated pre- and postinfection.

Authors:  S Ohya; Y Tanabe; M Makino; T Nomura; H Xiong; M Arakawa; M Mitsuyama
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  The 2-cys peroxiredoxin-deficient Listeria monocytogenes displays impaired growth and survival in the presence of hydrogen peroxide in vitro but not in mouse organs.

Authors:  Kwang-Pyo Kim; Byoung-Kwon Hahm; Arun K Bhunia
Journal:  Curr Microbiol       Date:  2007-05-05       Impact factor: 2.188

6.  Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages.

Authors:  Jesse T Myers; Albert W Tsang; Joel A Swanson
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

7.  Analgesic, anti-inflammatory and anticancer activities of Combretin A and Combretin B isolated from Combretum fragrans F. HOFFM (Combretaceae) leaves.

Authors:  Marius Mbiantcha; Jabeen Almas; Amadou Dawe; Aisha Faheem; Zafar Sidra
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

8.  Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates.

Authors:  J N Samsom; J A Langermans; P H Groeneveld; R van Furth
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei.

Authors:  Antje Bast; Imke H E Schmidt; Paul Brauner; Bettina Brix; Katrin Breitbach; Ivo Steinmetz
Journal:  Front Microbiol       Date:  2012-01-10       Impact factor: 5.640

10.  Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.

Authors:  T Fehr; G Schoedon; B Odermatt; T Holtschke; M Schneemann; M F Bachmann; T W Mak; I Horak; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.